Silence Therapeutics (SLN) Other Non Operating Income: 2020-2025
Historic Other Non Operating Income for Silence Therapeutics (SLN) over the last 6 years, with Sep 2025 value amounting to $1.9 million.
- Silence Therapeutics' Other Non Operating Income rose 116.97% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.1 million, marking a year-over-year decrease of 73.71%. This contributed to the annual value of $4.5 million for FY2024, which is 269.33% up from last year.
- Per Silence Therapeutics' latest filing, its Other Non Operating Income stood at $1.9 million for Q3 2025, which was up 129.25% from -$6.6 million recorded in Q2 2025.
- Silence Therapeutics' 5-year Other Non Operating Income high stood at $15.7 million for Q4 2024, and its period low was -$11.4 million during Q3 2024.
- For the 3-year period, Silence Therapeutics' Other Non Operating Income averaged around -$431,720, with its median value being $390,425 (2023).
- Within the past 5 years, the most significant YoY rise in Silence Therapeutics' Other Non Operating Income was 553.26% (2024), while the steepest drop was 1,609.52% (2024).
- MRQ analysis of 5 years shows Silence Therapeutics' Other Non Operating Income stood at -$106,493 in 2021, then crashed by 434.19% to -$568,870 in 2022, then plummeted by 587.04% to -$3.9 million in 2023, then skyrocketed by 502.67% to $15.7 million in 2024, then crashed by 87.71% to $1.9 million in 2025.
- Its Other Non Operating Income was $1.9 million in Q3 2025, compared to -$6.6 million in Q2 2025 and -$3.8 million in Q1 2025.